Related Experiment Video
Updated: Sep 9, 2025

Ileectomy-induced Bile Overaccumulation in Mouse Intestine
Published on: August 21, 2017
Exploring small intestinal bacterial overgrowth in functional upper gastrointestinal disorder: A comprehensive
Bhaswati C Acharyya1,2, Meghdeep Mukhopadhyay1
1Department of Pediatric Gastroenterology and Hepatology, Institute of Child Health, Kolkata 700017, West Bengal, India.
Small intestinal bacterial overgrowth (SIBO) is common in children with unexplained upper GI symptoms. Investigating SIBO in these pediatric patients is recommended, even with normal endoscopic findings.
Area of Science:
- Pediatric Gastroenterology
- Microbiome Research
- Diagnostic Accuracy
Background:
- Small intestinal bacterial overgrowth (SIBO) is frequently suspected in functional gastrointestinal disorders.
- Children with upper GI symptoms are often not tested for SIBO.
Purpose of the Study:
- To determine the prevalence of SIBO in children with functional upper GI symptoms.
- To compare SIBO status in children with and without endoscopic lesions.
Main Methods:
- 129 children (6-18 years) with upper GI symptoms underwent endoscopy before proton pump inhibitors (PPIs).
- Cases had normal endoscopy; controls had endoscopic lesions.
- Glucose-hydrogen breath tests diagnosed SIBO in both groups.
Main Results:
- SIBO was diagnosed in 59% of children with normal endoscopy (cases) versus 21% with lesions (controls).
- The odds ratio for SIBO in cases was 5.38, indicating a significant association.
- Nausea, halitosis, and epigastric fullness predicted SIBO in children.
Conclusions:
- SIBO investigation is valuable for children with upper GI symptoms unexplained by endoscopy.
- Early SIBO diagnosis and treatment can improve pediatric GI health outcomes.
Related Concept Videos
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

